Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases

International Journal of Oncology

Volumn 48, Issue 2, 2016, Pages 843-853

  Ma, Lijie ^a   Wang, Ruixuan ^a   Nan, Yandong ^a   Li, Wangping ^a   Wang, Qingwei ^a   Jin, Faguang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Invasion; Migration; Non small cell lung cancer; Phloretin

Indexed keywords

CASPASE 3; CASPASE 9; CISPLATIN; GELATINASE A; GELATINASE B; PHLORETIN; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL DENSITY; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOTION; DRUG EFFECTS; LUNG NEOPLASMS; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHLORETIN; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 84956901639     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3304     Document Type: Article

References (30)

1. Subramaniam S, Thakur RK, Yadav VK, Nanda R, Chowdhury S and Agrawal A: Lung cancer biomarkers: State of the art. J Carcinog 12: 3, 2013.
2. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working Group: Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
3. de Boer A, Vos E and Bast A: Implementation of the nutrition and health claim regulation-The case of antioxidants. Regul Toxicol Pharmacol 68: 475-487, 2014.
4. Zicker SC, Wedekind KJ and Jewell DE: Antioxidants in veterinary nutrition. Vet Clin North Am Small Anim Pract 36: 1183-1198, 2006.
5. Mandel S, Amit T, Reznichenko L, Weinreb O and Youdim MB: Green tea catechins as brain-permeable, natural iron chelatorsantioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res 50: 229-234, 2006.
6. Yang DS, Li ZL, Peng WB, Yang YP, Wang X, Liu KC, Li XL and Xiao WL: Three new prenylated flavonoids from Macaranga denticulata and their anticancer effects. Fitoterapia 103: 165-170, 2015.
7. Rezk BM, Haenen GR, van der Vijgh WJ and Bast A: The antioxidant activity of phloretin: The disclosure of a new antioxidant pharmacophore in flavonoids. Biochem Biophys Res Commun 295: 9-13, 2002.
8. Zhang S and Morris ME: Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 304: 1258-1267, 2003.
9. Pohl C, Will F, Dietrich H and Schrenk D: Cytochrome P450 1A1 expression and activity in Caco-2 cells: Modulation by apple juice extract and certain apple polyphenols. J Agric Food Chem 54: 10262-10268, 2006.
10. Nguyen H, Zhang S and Morris ME: Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci 92: 250-257, 2003.
11. Boyer J and Liu RH: Apple phytochemicals and their health benefits. Nutr J 3: 5, 2004.
12. Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18: 1414-1424, 2011.
13. X in M and Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280: 10781-10789, 2005.
14. Bayramoglu A, Gunes HV, Metintas M, Deʇirmenci I, Mutlu F and Alataş F: The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and-9 and TIMP-1,-2,-3, and-4 gene expression in lung cancer. Genet Test Mol Biomarkers 13: 671-678, 2009.
15. Yang KC, Tsai CY, Wang YJ, Wei PL, Lee CH, Chen JH, Wu CH and Ho YS: Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol Carcinog 48: 420-431, 2009.
16. Nelson JA and Falk RE: Phloridzin and phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in vitro and in vivo. Anticancer Res 13A: 2293-2299, 1993.
17. Nelson JA and Falk RE: The efficacy of phloridzin and phloretin on tumor cell growth. Anticancer Res 13A: 2287-2292, 1993.
18. Zhu SP, Liu G, Wu XT, Chen FX, Liu JQ, Zhou ZH, Zhang JF and Fei SJ: The effect of phloretin on human γδ T cells killing colon cancer SW-1116 cells. Int Immunopharmacol 15: 6-14, 2013.
19. Karunagaran D, Joseph J and Kumar TR: Cell growth regulation. Adv Exp Med Biol 595: 245-268, 2007.
20. Rong Y and Distelhorst CW: Bcl-2 protein family members: Versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol 70: 73-91, 2008.
21. Park HJ, Jeon YK, You DH and Nam MJ: Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol 60: 542-549, 2013.
22. Fennell DA: Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res 11: 2097-2105, 2005.
23. Balzer EM and Konstantopoulos K: Intercellular adhesion: Mechanisms for growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med 4: 171-181, 2012.
24. Guruvayoorappan C and Kuttan G: Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30: 711-727, 2008.
25. Chen RX, Xia YH, Xue TC, Zhang H and Ye SL: Downregulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Oncol Rep 25: 803-808, 2011.
26. Borkham-Kamphorst E, Alexi P, Tihaa L, Haas U and Weiskirchen R: Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities. Biochem Biophys Res Commun 457: 307-313, 2015.
27. D avis ME, Gumucio JP, Sugg KB, Bedi A and Mendias CL: MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix. J Appl Physiol 115: 884-891, 2013.
28. Wang R, Ke ZF, Wang F, Zhang WH, Wang YF, Li SH and Wang LT: GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9. Cell Physiol Biochem 35: 969-982, 2015.
29. X u X, Chen L, Xu B, Xie Q, Sun M, Deng X, Wu C and Jiang J: Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis. Int J Clin Exp Pathol 8: 1985-1990, 2015.
30. El-Badrawy MK, Yousef AM, Shaalan D and Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis. J Bronchol Interv Pulmonol 21: 327-334, 2014.